<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03716999</url>
  </required_header>
  <id_info>
    <org_study_id>Starlight Trial</org_study_id>
    <nct_id>NCT03716999</nct_id>
  </id_info>
  <brief_title>Starlight Therapy in Palliative Care</brief_title>
  <official_title>Starlight Therapy as a Non-Pharmacological Nursing Intervention in Palliative Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Starlight Therapy has been shown to help alleviate end-of-life symptoms in Palliative Care&#xD;
      patients and reduce the need for PRN or &quot;as needed&quot; medications. This study will investigate&#xD;
      the efficacy of this intervention using a mixed-method analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Starlight Therapy has been shown (see citation) to help alleviate end-of-life symptoms in&#xD;
      Palliative Care patients and reduce the need for PRN or &quot;as needed&quot; medications. This study&#xD;
      will investigate the efficacy of this intervention using a mixed-method analysis.&#xD;
&#xD;
      Starlight Therapy will be offered to patients with unpleasant end-of-life symptoms such as&#xD;
      dyspnea, agitation, anxiety, restlessness and insomnia. The effect the Starlight Therapy has&#xD;
      in helping alleviate these symptoms will be measured using the ESAS (Edmonton Symptom&#xD;
      Assessment System) questionnaire at baseline and following a predetermined period of time of&#xD;
      Starlight Therapy.&#xD;
&#xD;
      Three Starlight Projectors have been purchased for the unit where the study will take place:&#xD;
      the Inpatient Palliative Care Unit 7A, Victoria General Hospital, Centennial Building. The&#xD;
      funding was acquired by a Comfort &amp; Care Grant from the QEII Foundation.&#xD;
&#xD;
      The results will be compiled and analyzed in a research paper &quot;Concerning the Efficacy of&#xD;
      Starlight Therapy as a Non-Pharmacological Nursing Intervention for Palliative Care&#xD;
      Patients&quot;.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Using Starlight Therapy to measure Change in Unpleasant Symptoms in Palliative Care Patients as measured using the ESAS (Edmonton Symptom Assessment System) Scale. On a scale of 0-10, with 0 = no symptom and 10= symptom is worst outcome possible.</measure>
    <time_frame>2 hours of Starlight Therapy</time_frame>
    <description>Edmonton Assessment scale questionnaire will be completed before Starlight Therapy and after 2 hours.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Symptom Management</condition>
  <arm_group>
    <arm_group_label>Palliative Care Patients</arm_group_label>
    <description>Palliative care Patients meeting criteria will receive Starlight Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Starlight Therapy</intervention_name>
    <description>Starlight Projector will be placed in patients' rooms and project starlight on the ceilings and walls in an effort to reduce unpleasant symptoms</description>
    <arm_group_label>Palliative Care Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in an inpatient palliative care Setting who meet the specified criteria for&#xD;
        inclusion in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. ESAS indicates at least one of the following symptoms:&#xD;
&#xD;
          -  Insomnia&#xD;
&#xD;
          -  Anxiety&#xD;
&#xD;
          -  Restlessness&#xD;
&#xD;
          -  Dyspnea&#xD;
&#xD;
          -  Pain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Clinical Diagnosis of blindness&#xD;
&#xD;
          2. ESAS does not include any of the flowing symptoms:&#xD;
&#xD;
               -  Insomnia&#xD;
&#xD;
               -  Anxiety&#xD;
&#xD;
               -  Restlessness&#xD;
&#xD;
               -  Dyspnea&#xD;
&#xD;
               -  Pain&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>shelley A sandblom, BA, BScN, RN</last_name>
    <phone>902-449-6110</phone>
    <email>shelley.sandblom@nshealth.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Victoria General Hospital</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>https://journals.lww.com/jhpn/Citation/2017/06000/Evaluation_of_a_Low_Light_Intervention_Starlight.7.aspx</url>
    <description>Quantitative study on Starlight Therapy</description>
  </link>
  <reference>
    <citation>Evaluation of a Low-Light Intervention-Starlight Therapy-for Agitation, Anxiety, Restlessness, Sleep Disturbances, Dyspnea, and Pain at End of Life. (2017). Journal of Hospice &amp; Palliative Nursing, 19(3), 221-222. doi:10.1097/njh.0000000000000343</citation>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 18, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Shelley Sandblom</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>palliative</keyword>
  <keyword>starlight</keyword>
  <keyword>end-of-life symptoms</keyword>
  <keyword>non-pharmacological</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

